期刊文献+
共找到5篇文章
< 1 >
每页显示 20 50 100
国际疾病分类第9次修订码中先兆子痫诊断的准确性 被引量:1
1
作者 Geller S.E. Ahmed S. +1 位作者 Brown M.L. 成夜霞 《世界核心医学期刊文摘(妇产科学分册)》 2005年第1期12-13,共2页
Objective The purpose of this study was to evaluate the accuracy of t he Intern ational Classification of Diseases-9th revision codes for preeclampsia and ecla mpsia. Study design The University of Illinois Medical Ce... Objective The purpose of this study was to evaluate the accuracy of t he Intern ational Classification of Diseases-9th revision codes for preeclampsia and ecla mpsia. Study design The University of Illinois Medical Center at Chicago dischar ge database was used to identify 135 women from 1999 through 2001 whose disease was coded as having preeclampsia or eclampsia. With American College of Obstetri cs and Gynecology criteria as the gold standard, the diagnosis that was determin ed through chart review was compared with the International Classification of Di seases-9th revision code that was present in the discharge database. Patients w ere classified as true cases if the International Classification of Diseases-9t h revision code matched the American College of Obstetricians and Gynecologists diagnosis; the positive predictive value of the code was then calculated. Result s The overall positive predictive value for the complete sample was only 54%, b ut the positive predictive value for severe preeclampsia was 84.8%, which was h igh compared with mild preeclampsia (45.3%) and eclampsia (41.7%). Diagnostic (clinician) error was the most common reason for miscoding error. Conclusion The findings suggest that International Classification of Diseases-9th revision co des for preeclampsia/eclampsia vary greatly in their accuracy of diagnosis. Ther efore, a review of medical records is required when data are being gathered on t he incidence of preeclampsia and eclampsia. 展开更多
关键词 国际疾病分类 先兆子痫 阳性预测值 间记录 有显著性差异 金标准 诊断标准 大学医学中心 临床医生 诺斯
下载PDF
THE STRUCTURE OF ASTERBATANOSIDE J FROM ASTER BATANGENSIS 被引量:1
2
作者 Shao, Y Zhou, BN +1 位作者 Lin, LZ Cordell, GA 《Chinese Chemical Letters》 SCIE CAS CSCD 1995年第3期221-224,共4页
A new medicagenic acid saponin named asterbatanoside J was isolated from the roots of Aster batangensis. On the basis of chemical and spectral studies especially 2D NMR including COSY, HETCOR, HOHAHA, ROESY and HMBC t... A new medicagenic acid saponin named asterbatanoside J was isolated from the roots of Aster batangensis. On the basis of chemical and spectral studies especially 2D NMR including COSY, HETCOR, HOHAHA, ROESY and HMBC techniques, its structure has been established as 3-O-beta -D-glucopyranosyl-(1 -->6)-beta -D-glucopyranosyl-2 beta ,3 beta -dihydroxy-olean-12-en-23 alpha ,28-dioic acid-28-O-alpha -L-arabinopyranosyl-(1 -->3)-alpha -L-rhamnopyranosyl-(1 -->2)-beta -D-fucopyranoside. 展开更多
下载PDF
TWONEW TRITERPENOID SAPONINS,ASTERBATANOSIDE H AND I,FROM ASTER BATANGENSIS 被引量:1
3
作者 Shao, Y Zhou, BN +1 位作者 Lin, LZ Cordell, GA 《Chinese Chemical Letters》 SCIE CAS CSCD 1995年第2期105-108,共4页
Two new triterpenoid saponins named asterbatanoside H and I have been isolated from the roots of Aster batsngensis and their structures elucidated as 3-O-β-D-glucopyranosyl-(1→3) β-D-glucopyranosyl-bayogenin-28-O-... Two new triterpenoid saponins named asterbatanoside H and I have been isolated from the roots of Aster batsngensis and their structures elucidated as 3-O-β-D-glucopyranosyl-(1→3) β-D-glucopyranosyl-bayogenin-28-O-β-D-glucopyranosyl-(1→6)-β-D-glucopyranosy-(1→6) and 3-O-β-D-glucopyranosyl-(1→3)-β-D-glucopyranosyl-23-O-acetyl-bayogenin-28-O-β-D-glucopyranosyl-(1→6) β-D-glucopyranoside, respectively, by means of spectral and chemical data. 展开更多
下载PDF
两个不同部位长期留置外科中央静脉导管的新生儿病例的预后差异:颈部和腹股沟区
4
作者 Vegunta R.K. Loethen P. +1 位作者 Wallace L.J. 朱新菊 《世界核心医学期刊文摘(儿科学分册)》 2005年第9期30-30,共1页
Long-term tunneled central venous catheters (CVC) are frequently used in the neonatal intensive care unit (NICU) babies. They are placed either in the neck or groin based primarily upon the surgeon’ s preference. The... Long-term tunneled central venous catheters (CVC) are frequently used in the neonatal intensive care unit (NICU) babies. They are placed either in the neck or groin based primarily upon the surgeon’ s preference. There is meager published in-formation available about the relative risks of these lines. This is a retrospective analysis of all the tunneled central venous catheters placed in NICU babies at a children’ s hospital over a nearly 5-year period. Single lumen Broviac catheters were used in all cases. A total of 137 catheters were placed in 126 patients. There were 88 neck lines and 49 groin lines. Age, gestational maturity, and body weight were significantly lower for babies who underwent groin line placement. There was no significant difference in the number of days the catheters were live between the 2 groups. Total complication rates and catheter infection rates were significantly higher with neck lines. The accidental removal rate was higher with neck lines but did not reach statistical significance. Broviac catheters placed in the groin of NICU babies are associated with significantly fewer complications compared with those placed in the neck. 展开更多
关键词 新生儿病 中央静脉导管 腹股沟区 静脉留置导管 儿童医院 手术医师 统计学显著性 风险值 单腔 个人习惯
下载PDF
Nature:通过控制血管生长来开发治疗癌症等多种疾病的新型疗法 被引量:19
5
作者 Yu, Pengchun Wilhelm, Kerstin +19 位作者 Dubrac, Alexandre Tung, Joe K. Alves, Tiago C. Fang, Jennifer S. Xie, Yi Zhu, Jie Chen, Zehua De Smet, Frederik Zhang, Jiasheng Jin, Suk-Won Sun, Lele Sun, Hongye Kibbey, Richard G. Hirschi, Karen K. Hay, Nissim Carmeliet, Peter Chittenden, Thomas W. Eichmann, Anne Potente, Michael Simons, Michael 《现代生物医学进展》 CAS 2017年第22期I0002-I0002,共1页
最近,一项刊登在国际杂志Nature上的研究报告中,来自耶鲁大学的研究人员通过研究揭示了如何通过控制血管发育来帮助开发治疗心血管疾病以及癌症的新型疗法。
关键词 心血管疾病 疗法 癌症 治疗 开发 控制 生长 血管发育
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部